<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02803684</url>
  </required_header>
  <id_info>
    <org_study_id>PA12065</org_study_id>
    <nct_id>NCT02803684</nct_id>
  </id_info>
  <brief_title>Contribution of Diffusion MRI in Renal Graft Transplantation</brief_title>
  <official_title>Diagnostic Ability of Diffusion MRI and Diffusion Tensor in Renal Graft Biopsies: Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Reims</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      While renal graft outcomes were really improved for the last decade, long time outcomes&#xD;
      remains stable. Indeed, at 10 years after transplantation, the renal graft survival rate&#xD;
      reaches 50%. The chronic allograft nephropathy is the main cause of renal graft loss. Other&#xD;
      features such as acute allograft rejection, delayed renal recovery and anti-human leukocyte&#xD;
      antigen (anti-HLA) antibodies are associated with poor renal graft survival prognosis. Renal&#xD;
      graft protocol biopsies at 3 and 12 months after transplantation are valuable to detect&#xD;
      precociously renal injuries at a reversible stage before clinical manifestation. However,&#xD;
      renal biopsy is an invasive examination with hemorrhagic risk. Diffusion MRI could be a&#xD;
      non-invasive diagnostic tool allowing the early detection of renal injuries, especially&#xD;
      allograft rejection without hemorrhagic risk. This tool could be applied routinely to the&#xD;
      renal allograft recipient in replacement of protocol biopsies.&#xD;
&#xD;
      Here, aim of this study is to correlate the results from diffusion MRI of renal graft with&#xD;
      pathologic findings from protocol renal graft biopsies.&#xD;
&#xD;
      In this view, the investigators include prospectively all recipients of renal transplantation&#xD;
      who beneficiate of a protocol renal graft biopsy without barrier to peform MRI examination.&#xD;
      Thus, the investigators exclude patients who are not be able to beneficiate of a MRI&#xD;
      examination and patient obstacle to renal graft biopsy.&#xD;
&#xD;
      Expected results are the Banff classification from the histopathologic analysis of biopsies.&#xD;
      The expected results for MRI examination are signal intensity, diffusive coefficient,&#xD;
      anisotropy fraction and change of the diffusion way. Next, the investigators search an&#xD;
      association between these features by statistical analysis (Wilcoxon test, ChiÂ², Fisher,&#xD;
      Pearson or Spearman).&#xD;
&#xD;
      The investigators performed this study since 01/06/2014 and projected end-time to 01/06/2017.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Signal intensity by Diffusion MRI</measure>
    <time_frame>since transplantation to 12 months after</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Banff score (histopathologic findings)</measure>
    <time_frame>since transplantation to 12 months after</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Renal Transplantation</condition>
  <arm_group>
    <arm_group_label>Single arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Whole cohort</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI examination with tensor diffusion protocol acquisition. No injection needed.</intervention_name>
    <description>standard MRI examination</description>
    <arm_group_label>Single arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Renal graft recipient from Reims hospital&#xD;
&#xD;
          -  Over 18 years&#xD;
&#xD;
          -  With consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chu de Reims</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent VUIBLET</last_name>
      <email>vvuiblet@chu-reims.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <study_first_submitted>June 8, 2016</study_first_submitted>
  <study_first_submitted_qc>June 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2016</study_first_posted>
  <last_update_submitted>June 14, 2016</last_update_submitted>
  <last_update_submitted_qc>June 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

